This report contains market size and forecasts of Anticonvulsants in global, including the following market information:
Global Anticonvulsants Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Anticonvulsants Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Anticonvulsants companies in 2020 (%)
The global Anticonvulsants market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Anticonvulsants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticonvulsants Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anticonvulsants Market Segment Percentages, By Type, 2020 (%)
Epilepsy
Fibromyalgia
Migraine
Neuropathic Pain
Bipolar Disorder
Anxiety
Borderline Personality Disorder
Global Anticonvulsants Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anticonvulsants Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Home Care
Global Anticonvulsants Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anticonvulsants Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticonvulsants revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Anticonvulsants revenues share in global market, 2020 (%)
Key companies Anticonvulsants sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Anticonvulsants sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson (J&J)
Novartis AG
UCB Group
GlaxoSmithKline plc.
Pfizer Inc.
Abbott Laboratories
Cephalon Inc.
Takeda
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anticonvulsants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticonvulsants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticonvulsants Overall Market Size
2.1 Global Anticonvulsants Market Size: 2021 VS 2027
2.2 Global Anticonvulsants Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anticonvulsants Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anticonvulsants Players in Global Market
3.2 Top Global Anticonvulsants Companies Ranked by Revenue
3.3 Global Anticonvulsants Revenue by Companies
3.4 Global Anticonvulsants Sales by Companies
3.5 Global Anticonvulsants Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anticonvulsants Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anticonvulsants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anticonvulsants Players in Global Market
3.8.1 List of Global Tier 1 Anticonvulsants Companies
3.8.2 List of Global Tier 2 and Tier 3 Anticonvulsants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anticonvulsants Market Size Markets, 2021 & 2027
4.1.2 Epilepsy
4.1.3 Fibromyalgia
4.1.4 Migraine
4.1.5 Neuropathic Pain
4.1.6 Bipolar Disorder
4.1.7 Anxiety
4.1.8 Borderline Personality Disorder
4.2 By Type - Global Anticonvulsants Revenue & Forecasts
4.2.1 By Type - Global Anticonvulsants Revenue, 2016-2021
4.2.2 By Type - Global Anticonvulsants Revenue, 2022-2027
4.2.3 By Type - Global Anticonvulsants Revenue Market Share, 2016-2027
4.3 By Type - Global Anticonvulsants Sales & Forecasts
4.3.1 By Type - Global Anticonvulsants Sales, 2016-2021
4.3.2 By Type - Global Anticonvulsants Sales, 2022-2027
4.3.3 By Type - Global Anticonvulsants Sales Market Share, 2016-2027
4.4 By Type - Global Anticonvulsants Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anticonvulsants Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application - Global Anticonvulsants Revenue & Forecasts
5.2.1 By Application - Global Anticonvulsants Revenue, 2016-2021
5.2.2 By Application - Global Anticonvulsants Revenue, 2022-2027
5.2.3 By Application - Global Anticonvulsants Revenue Market Share, 2016-2027
5.3 By Application - Global Anticonvulsants Sales & Forecasts
5.3.1 By Application - Global Anticonvulsants Sales, 2016-2021
5.3.2 By Application - Global Anticonvulsants Sales, 2022-2027
5.3.3 By Application - Global Anticonvulsants Sales Market Share, 2016-2027
5.4 By Application - Global Anticonvulsants Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anticonvulsants Market Size, 2021 & 2027
6.2 By Region - Global Anticonvulsants Revenue & Forecasts
6.2.1 By Region - Global Anticonvulsants Revenue, 2016-2021
6.2.2 By Region - Global Anticonvulsants Revenue, 2022-2027
6.2.3 By Region - Global Anticonvulsants Revenue Market Share, 2016-2027
6.3 By Region - Global Anticonvulsants Sales & Forecasts
6.3.1 By Region - Global Anticonvulsants Sales, 2016-2021
6.3.2 By Region - Global Anticonvulsants Sales, 2022-2027
6.3.3 By Region - Global Anticonvulsants Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anticonvulsants Revenue, 2016-2027
6.4.2 By Country - North America Anticonvulsants Sales, 2016-2027
6.4.3 US Anticonvulsants Market Size, 2016-2027
6.4.4 Canada Anticonvulsants Market Size, 2016-2027
6.4.5 Mexico Anticonvulsants Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anticonvulsants Revenue, 2016-2027
6.5.2 By Country - Europe Anticonvulsants Sales, 2016-2027
6.5.3 Germany Anticonvulsants Market Size, 2016-2027
6.5.4 France Anticonvulsants Market Size, 2016-2027
6.5.5 U.K. Anticonvulsants Market Size, 2016-2027
6.5.6 Italy Anticonvulsants Market Size, 2016-2027
6.5.7 Russia Anticonvulsants Market Size, 2016-2027
6.5.8 Nordic Countries Anticonvulsants Market Size, 2016-2027
6.5.9 Benelux Anticonvulsants Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anticonvulsants Revenue, 2016-2027
6.6.2 By Region - Asia Anticonvulsants Sales, 2016-2027
6.6.3 China Anticonvulsants Market Size, 2016-2027
6.6.4 Japan Anticonvulsants Market Size, 2016-2027
6.6.5 South Korea Anticonvulsants Market Size, 2016-2027
6.6.6 Southeast Asia Anticonvulsants Market Size, 2016-2027
6.6.7 India Anticonvulsants Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anticonvulsants Revenue, 2016-2027
6.7.2 By Country - South America Anticonvulsants Sales, 2016-2027
6.7.3 Brazil Anticonvulsants Market Size, 2016-2027
6.7.4 Argentina Anticonvulsants Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anticonvulsants Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anticonvulsants Sales, 2016-2027
6.8.3 Turkey Anticonvulsants Market Size, 2016-2027
6.8.4 Israel Anticonvulsants Market Size, 2016-2027
6.8.5 Saudi Arabia Anticonvulsants Market Size, 2016-2027
6.8.6 UAE Anticonvulsants Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson (J&J)
7.1.1 Johnson & Johnson (J&J) Corporate Summary
7.1.2 Johnson & Johnson (J&J) Business Overview
7.1.3 Johnson & Johnson (J&J) Anticonvulsants Major Product Offerings
7.1.4 Johnson & Johnson (J&J) Anticonvulsants Sales and Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson (J&J) Key News
7.2 Novartis AG
7.2.1 Novartis AG Corporate Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Anticonvulsants Major Product Offerings
7.2.4 Novartis AG Anticonvulsants Sales and Revenue in Global (2016-2021)
7.2.5 Novartis AG Key News
7.3 UCB Group
7.3.1 UCB Group Corporate Summary
7.3.2 UCB Group Business Overview
7.3.3 UCB Group Anticonvulsants Major Product Offerings
7.3.4 UCB Group Anticonvulsants Sales and Revenue in Global (2016-2021)
7.3.5 UCB Group Key News
7.4 GlaxoSmithKline plc.
7.4.1 GlaxoSmithKline plc. Corporate Summary
7.4.2 GlaxoSmithKline plc. Business Overview
7.4.3 GlaxoSmithKline plc. Anticonvulsants Major Product Offerings
7.4.4 GlaxoSmithKline plc. Anticonvulsants Sales and Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline plc. Key News
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Anticonvulsants Major Product Offerings
7.5.4 Pfizer Inc. Anticonvulsants Sales and Revenue in Global (2016-2021)
7.5.5 Pfizer Inc. Key News
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Corporate Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Anticonvulsants Major Product Offerings
7.6.4 Abbott Laboratories Anticonvulsants Sales and Revenue in Global (2016-2021)
7.6.5 Abbott Laboratories Key News
7.7 Cephalon Inc.
7.7.1 Cephalon Inc. Corporate Summary
7.7.2 Cephalon Inc. Business Overview
7.7.3 Cephalon Inc. Anticonvulsants Major Product Offerings
7.4.4 Cephalon Inc. Anticonvulsants Sales and Revenue in Global (2016-2021)
7.7.5 Cephalon Inc. Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Anticonvulsants Major Product Offerings
7.8.4 Takeda Anticonvulsants Sales and Revenue in Global (2016-2021)
7.8.5 Takeda Key News
8 Global Anticonvulsants Production Capacity, Analysis
8.1 Global Anticonvulsants Production Capacity, 2016-2027
8.2 Anticonvulsants Production Capacity of Key Manufacturers in Global Market
8.3 Global Anticonvulsants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anticonvulsants Supply Chain Analysis
10.1 Anticonvulsants Industry Value Chain
10.2 Anticonvulsants Upstream Market
10.3 Anticonvulsants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anticonvulsants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Anticonvulsants in Global Market
Table 2. Top Anticonvulsants Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anticonvulsants Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anticonvulsants Revenue Share by Companies, 2016-2021
Table 5. Global Anticonvulsants Sales by Companies, (K Units), 2016-2021
Table 6. Global Anticonvulsants Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anticonvulsants Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Anticonvulsants Product Type
Table 9. List of Global Tier 1 Anticonvulsants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticonvulsants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Anticonvulsants Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anticonvulsants Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anticonvulsants Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anticonvulsants Sales (K Units), 2016-2021
Table 15. By Type - Global Anticonvulsants Sales (K Units), 2022-2027
Table 16. By Application - Global Anticonvulsants Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anticonvulsants Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anticonvulsants Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anticonvulsants Sales (K Units), 2016-2021
Table 20. By Application - Global Anticonvulsants Sales (K Units), 2022-2027
Table 21. By Region - Global Anticonvulsants Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anticonvulsants Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anticonvulsants Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anticonvulsants Sales (K Units), 2016-2021
Table 25. By Region - Global Anticonvulsants Sales (K Units), 2022-2027
Table 26. By Country - North America Anticonvulsants Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anticonvulsants Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anticonvulsants Sales, (K Units), 2016-2021
Table 29. By Country - North America Anticonvulsants Sales, (K Units), 2022-2027
Table 30. By Country - Europe Anticonvulsants Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anticonvulsants Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anticonvulsants Sales, (K Units), 2016-2021
Table 33. By Country - Europe Anticonvulsants Sales, (K Units), 2022-2027
Table 34. By Region - Asia Anticonvulsants Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anticonvulsants Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anticonvulsants Sales, (K Units), 2016-2021
Table 37. By Region - Asia Anticonvulsants Sales, (K Units), 2022-2027
Table 38. By Country - South America Anticonvulsants Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anticonvulsants Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anticonvulsants Sales, (K Units), 2016-2021
Table 41. By Country - South America Anticonvulsants Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Anticonvulsants Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anticonvulsants Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anticonvulsants Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Anticonvulsants Sales, (K Units), 2022-2027
Table 46. Johnson & Johnson (J&J) Corporate Summary
Table 47. Johnson & Johnson (J&J) Anticonvulsants Product Offerings
Table 48. Johnson & Johnson (J&J) Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Novartis AG Corporate Summary
Table 50. Novartis AG Anticonvulsants Product Offerings
Table 51. Novartis AG Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. UCB Group Corporate Summary
Table 53. UCB Group Anticonvulsants Product Offerings
Table 54. UCB Group Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. GlaxoSmithKline plc. Corporate Summary
Table 56. GlaxoSmithKline plc. Anticonvulsants Product Offerings
Table 57. GlaxoSmithKline plc. Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Pfizer Inc. Corporate Summary
Table 59. Pfizer Inc. Anticonvulsants Product Offerings
Table 60. Pfizer Inc. Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Abbott Laboratories Corporate Summary
Table 62. Abbott Laboratories Anticonvulsants Product Offerings
Table 63. Abbott Laboratories Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Cephalon Inc. Corporate Summary
Table 65. Cephalon Inc. Anticonvulsants Product Offerings
Table 66. Cephalon Inc. Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Takeda Corporate Summary
Table 68. Takeda Anticonvulsants Product Offerings
Table 69. Takeda Anticonvulsants Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Anticonvulsants Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 71. Global Anticonvulsants Capacity Market Share of Key Manufacturers, 2019-2021
Table 72. Global Anticonvulsants Production by Region, 2016-2021 (K Units)
Table 73. Global Anticonvulsants Production by Region, 2022-2027 (K Units)
Table 74. Anticonvulsants Market Opportunities & Trends in Global Market
Table 75. Anticonvulsants Market Drivers in Global Market
Table 76. Anticonvulsants Market Restraints in Global Market
Table 77. Anticonvulsants Raw Materials
Table 78. Anticonvulsants Raw Materials Suppliers in Global Market
Table 79. Typical Anticonvulsants Downstream
Table 80. Anticonvulsants Downstream Clients in Global Market
Table 81. Anticonvulsants Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anticonvulsants Segment by Type
Figure 2. Anticonvulsants Segment by Application
Figure 3. Global Anticonvulsants Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anticonvulsants Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anticonvulsants Revenue, 2016-2027 (US$, Mn)
Figure 7. Anticonvulsants Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anticonvulsants Revenue in 2020
Figure 9. By Type - Global Anticonvulsants Sales Market Share, 2016-2027
Figure 10. By Type - Global Anticonvulsants Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anticonvulsants Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Anticonvulsants Sales Market Share, 2016-2027
Figure 13. By Application - Global Anticonvulsants Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anticonvulsants Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Anticonvulsants Sales Market Share, 2016-2027
Figure 16. By Region - Global Anticonvulsants Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anticonvulsants Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anticonvulsants Sales Market Share, 2016-2027
Figure 19. US Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anticonvulsants Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anticonvulsants Sales Market Share, 2016-2027
Figure 24. Germany Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 25. France Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anticonvulsants Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anticonvulsants Sales Market Share, 2016-2027
Figure 33. China Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 37. India Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anticonvulsants Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anticonvulsants Sales Market Share, 2016-2027
Figure 40. Brazil Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anticonvulsants Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anticonvulsants Sales Market Share, 2016-2027
Figure 44. Turkey Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anticonvulsants Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anticonvulsants Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Anticonvulsants by Region, 2020 VS 2027
Figure 50. Anticonvulsants Industry Value Chain
Figure 51. Marketing Channels
Johnson & Johnson (J&J)
Novartis AG
UCB Group
GlaxoSmithKline plc.
Pfizer Inc.
Abbott Laboratories
Cephalon Inc.
Takeda